Biomarkers Summit March 18-20,2015 San Diego, CA

The Biomarker Summit 2015, to be held on March 18-20, 2015 in San Diego, CA at the Westin San Diego Hotel, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in three major therapeutic areas, formally organized in the following tracks:

General Sessions (Joint):
I. Plenary Keynote Session
II. Big Data Analytics for Biomarkers Development
III. Novel Technologies in Biomarker Development
IV. Overcoming Challenges of Clinical Validation & Translation
V. Panel Discussion: Companion Diagnostics Development & Partnering Strategies
VI. Panel Discussion: Non-profits Perspectives on Biomarkers
VII. Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development

8th Oncology Biomarkers
I. Liquid Biopsy: Non Invasive Approaches to Diagnostics
II. Digital & Molecular Pathology
III. Emerging Discovery Pipelines
IV. ImmunoOncology Biomarker Discovery


4th Neurological Biomarkers
I. Imaging Approaches in CNS Drug Discovery & Development
II. CSF & Blood Based Biomarker Approaches
III. Developments in Neurological & Neurodegenerative Disorders
IV. Biomarker Development in Neuropsychiatric Disorders

4th Inflammatory / Immunological Biomarkers
I. Biomarkers of Early Progressive Inflammatory & Immunological Diseases
II. Biomarkers & Surrogate Endpoints for Clinical Trials in Inflammatory Diseases
III. Novel Approaches to Immunological Biomarkers
IV. Fluid Based Biomarker Approaches (Synovial, Salivary, Urine)

Biomarkers Summit March 18-20,2015 San Diego, CA

The Biomarker Summit 2015, to be held on March 18-20, 2015 in San Diego, CA at the Westin San Diego Hotel, is a meeting place for leaders in the field to discuss the issues and challenges scientists and researchers face in all aspects of the biomarker and diagnostic development process from discovery to translation to commercialization.

A wide variety of important topics will be covered including biomarker identification, validation, and translation strategies, bioinformatics and systems biology approaches to personalized medicine, big data analytics and management, regulatory and reimbursement trends, companion diagnostics development, and much more. Through scientific presentations, case studies and panel discussions, these areas will be addressed in an intimate and highly interactive environment with perspectives from industry, academia and the public sector.

Assembling leading scientists, researchers, decision-makers and other players across the industry spectrum, the Summit provides a unique opportunity to gain the latest biomarker developments in three major therapeutic areas, formally organized in the following tracks:

General Sessions (Joint):
I. Plenary Keynote Session
II. Big Data Analytics for Biomarkers Development
III. Novel Technologies in Biomarker Development
IV. Overcoming Challenges of Clinical Validation & Translation
V. Panel Discussion: Companion Diagnostics Development & Partnering Strategies
VI. Panel Discussion: Non-profits Perspectives on Biomarkers
VII. Panel Discussion: Regulatory & Reimbursement Trends in Biomarker Development

8th Oncology Biomarkers
I. Liquid Biopsy: Non Invasive Approaches to Diagnostics
II. Digital & Molecular Pathology
III. Emerging Discovery Pipelines
IV. ImmunoOncology Biomarker Discovery


4th Neurological Biomarkers
I. Imaging Approaches in CNS Drug Discovery & Development
II. CSF & Blood Based Biomarker Approaches
III. Developments in Neurological & Neurodegenerative Disorders
IV. Biomarker Development in Neuropsychiatric Disorders

4th Inflammatory / Immunological Biomarkers
I. Biomarkers of Early Progressive Inflammatory & Immunological Diseases
II. Biomarkers & Surrogate Endpoints for Clinical Trials in Inflammatory Diseases
III. Novel Approaches to Immunological Biomarkers
IV. Fluid Based Biomarker Approaches (Synovial, Salivary, Urine)

7th Ocular Diseases Drug Discovery March 19-20,2015 San Diego, CA

The 7th Ocular Diseases Drug Discovery Conference is taking place on March 19-20, 2015 in San Diego, CA. The conference continues to offer presentations on novel therapeutics in ocular drug development and discovery. This is a platform for excellent networking, exchanging ideas, and sharing challenges; all with a united goal of bringing innovative and progressive treatments to patients in the field of ophthalmology.

Topics to be discussed:

The conference promotes the discovery of drug development and therapeutics in ocular diseases by gathering leading scientists, researchers, and experts to discuss and collaborate on the latest R&D, safety assessment, regulatory issues, and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), uveitis, and other ocular diseases.

 

7th Ocular Diseases Drug Discovery March 19-20,2015 San Diego, CA

The 7th Ocular Diseases Drug Discovery Conference is taking place on March 19-20, 2015 in San Diego, CA. The conference continues to offer presentations on novel therapeutics in ocular drug development and discovery. This is a platform for excellent networking, exchanging ideas, and sharing challenges; all with a united goal of bringing innovative and progressive treatments to patients in the field of ophthalmology.

Topics to be discussed:

The conference promotes the discovery of drug development and therapeutics in ocular diseases by gathering leading scientists, researchers, and experts to discuss and collaborate on the latest R&D, safety assessment, regulatory issues, and drugs in development for combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), uveitis, and other ocular diseases.

 

Society of Toxicology Annual Meeting & ToxExpo March 22 - 26, 2015 San Diego, CA

The SOT Annual Meeting is the largest meeting of its kind. This annual event features a broad range of scientific sessions and a thematic program that provides partici-pants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes a plenary session, the MRC Lecture, symposia, work-shops, roundtable discussions, informational sessions, regional sessions, as well as platform and poster sessions. The Society anticipates that more than 6,500 toxicologists from more than 50 countries will attend. The SOT Annual Meeting also features the ToxExpo, which is the largest exhibition dedicated to toxicology and the biomedical sciences. The exhibition features 350 exhibitors, exhibitor-hosted sessions, and the opportunity to debut cutting-edge products, services, and technologies.

ToxExpo Attendees Are Engaged in One or More of the Following Areas of Research

Society of Toxicology Annual Meeting & ToxExpo March 22 - 26, 2015 San Diego, CA

The SOT Annual Meeting is the largest meeting of its kind. This annual event features a broad range of scientific sessions and a thematic program that provides partici-pants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes a plenary session, the MRC Lecture, symposia, work-shops, roundtable discussions, informational sessions, regional sessions, as well as platform and poster sessions. The Society anticipates that more than 6,500 toxicologists from more than 50 countries will attend. The SOT Annual Meeting also features the ToxExpo, which is the largest exhibition dedicated to toxicology and the biomedical sciences. The exhibition features 350 exhibitors, exhibitor-hosted sessions, and the opportunity to debut cutting-edge products, services, and technologies.

ToxExpo Attendees Are Engaged in One or More of the Following Areas of Research

Society of Toxicology Annual Meeting & ToxExpo March 22 - 26, 2015 San Diego, CA

The SOT Annual Meeting is the largest meeting of its kind. This annual event features a broad range of scientific sessions and a thematic program that provides partici-pants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes a plenary session, the MRC Lecture, symposia, work-shops, roundtable discussions, informational sessions, regional sessions, as well as platform and poster sessions. The Society anticipates that more than 6,500 toxicologists from more than 50 countries will attend. The SOT Annual Meeting also features the ToxExpo, which is the largest exhibition dedicated to toxicology and the biomedical sciences. The exhibition features 350 exhibitors, exhibitor-hosted sessions, and the opportunity to debut cutting-edge products, services, and technologies.

ToxExpo Attendees Are Engaged in One or More of the Following Areas of Research

Paediatric Clinical Trials 25th - 26th March 2015, London, UK

A large number of medicines used in paediactric care have not been tested on children and are therefore used off lable or unlicensed. This absence of suitable authorised medicinal products to treat conditions in children is an issue that has been of concern for some time, and one that is increasingly coming to the fore.

Returning for its ninth year as an industry leading event, SMI are proud to present the 9th annual Paediatric Clinical Trials Conference, 25th - 26th March 2015, London. This event will look at the paediatric therapeutic developments, directives and procedures which have been put in place to protect children taking part in clinical trials.

Key topics include:
• Guidelines on the Paediactric Investigation Plan (PIP) – strategies to overcome any challenges
• Formulating meaningful statistics with a limited patient population
• Site selection and feasibility- identifying appropriate clinical trial sites
• Optimizing patient retention strategies for successful trial development

Superbugs & Superdrugs 25th March to 26th March 2015, London, United Kingdom

Antibiotics have been one of the most transformational discoveries in medicine saving millions of lives around the world. The rise of resistance poses an unprecedented threat to public health rekindling a drive for new, effective and safe drugs to beat the superbugs, combined with efforts to raise awareness around the use of antimicrobials.

This conference takes a holistic look at the issues and aims to equip delegates to take on the challenges of conserving the effectiveness of existing antibacterial drugs, developing new ones and tackling biosecuiry and Ebola threats. Bringing in voices from pharma, academia, government, regulatory perspectives, consultants and funding bodies this conference is the ideal meeting place to share the latest updates, case studies and strategies to seize the opportunities ahead and  usher in the next generation of superdrugs.

Paediatric Clinical Trials 25th - 26th March 2015, London, UK

A large number of medicines used in paediactric care have not been tested on children and are therefore used off lable or unlicensed. This absence of suitable authorised medicinal products to treat conditions in children is an issue that has been of concern for some time, and one that is increasingly coming to the fore.

Returning for its ninth year as an industry leading event, SMI are proud to present the 9th annual Paediatric Clinical Trials Conference, 25th - 26th March 2015, London. This event will look at the paediatric therapeutic developments, directives and procedures which have been put in place to protect children taking part in clinical trials.

Key topics include:
• Guidelines on the Paediactric Investigation Plan (PIP) – strategies to overcome any challenges
• Formulating meaningful statistics with a limited patient population
• Site selection and feasibility- identifying appropriate clinical trial sites
• Optimizing patient retention strategies for successful trial development

Superbugs & Superdrugs 25th March to 26th March 2015, London, United Kingdom

Antibiotics have been one of the most transformational discoveries in medicine saving millions of lives around the world. The rise of resistance poses an unprecedented threat to public health rekindling a drive for new, effective and safe drugs to beat the superbugs, combined with efforts to raise awareness around the use of antimicrobials.

This conference takes a holistic look at the issues and aims to equip delegates to take on the challenges of conserving the effectiveness of existing antibacterial drugs, developing new ones and tackling biosecuiry and Ebola threats. Bringing in voices from pharma, academia, government, regulatory perspectives, consultants and funding bodies this conference is the ideal meeting place to share the latest updates, case studies and strategies to seize the opportunities ahead and  usher in the next generation of superdrugs.